Vortioxetine for Newly Diagnosed Glioblastoma
NCT07284628
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Glioblastoma
Interventions
DRUG:
Vortioxetine
Sponsor
University of Zurich
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]